NCT07541664 2026-04-21
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
Fudan University
Phase NA Recruiting
Clinical Trials
7 trialsNCT07054242 2025-10-01
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)
Yantai Yuhuangding Hospital
Phase 2 Not yet recruiting
NCT06734702 2025-07-24
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Recruiting
NCT06913777 2025-06-06
Neoadjuvant SNF Precision Therapy Phase III
Fudan University
Phase 3 Recruiting
NCT05376722 2023-01-05
A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT05406999 2022-08-16
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Recruiting
NCT05352165 2022-04-28
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer
Shanghai Minimally Invasive Surgery Center
Phase NA Unknown